Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin.

British Journal of Clinical Pharmacology
Manabu TashiroKazuhiko Yanai

Abstract

'Bepotastine besilate' is a novel second-generation antihistamine developed in Japan and its antiallergic effects have already been demonstrated by various studies. However, only a few clinical studies regarding its sedative property are available. In addition, histamine H(1) receptor occupancy (H(1)RO) of this new antihistamine has never been measured by positron emission tomography (PET). This paper provides the first measurement result of cerebral H(1)RO of bepotastine besilate (approximately 15%) as determined by PET. This result is in accordance with the clinical classification of bepotastine as a second-generation antihistamine. In addition, the relationship between subjective sleepiness and cerebral H(1)RO of this second-generation antihistamine is demonstrated for the first time using a placebo-controlled crossover study design. AIMS Antihistamines are frequently used for treating various allergic diseases, but often induce sedation. The degree of sedation can be evaluated by measuring histamine H(1) receptor occupancy (H(1)RO) in the brain using positron emission tomography (PET). The aim was to measure H(1)RO of bepotastine, a new second-generation antihistamine, and to compare it with that of diphenhydramine. Eight h...Continue Reading

References

Jun 18, 1984·Brain Research·S Kanba, E Richelson
Nov 12, 1996·Proceedings of the National Academy of Sciences of the United States of America·I InoueT Watanabe
Jul 1, 1997·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·N YatoH Narita
Feb 14, 1998·Annals of Nuclear Medicine·T FujiwaraS Takahashi
Jul 28, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·F D Martinez
Aug 12, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·K YanaiT Watanabe
Aug 12, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·G G Kay, A G Harris
Feb 13, 2001·Progress in Neurobiology·R E BrownH L Haas
Feb 13, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·D MartinezM Laruelle
May 8, 2001·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·R IwataT Ido
Sep 6, 2001·Pharmacogenomics·D MartinezM Laruelle
May 11, 2002·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·I HindmarchS Kimber
Feb 4, 2003·Nature Reviews. Neuroscience·Helmut Haas, Pertti Panula
May 14, 2003·The Journal of Allergy and Clinical Immunology·Thomas B CasaleUNKNOWN Antihistamine Impairment Roundtable
Sep 6, 2003·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·S T HolgateUNKNOWN Consensus Group on New-Generation Antihistamines
Sep 26, 2003·Journal of Dermatological Science·Takeshi NakaharaMasutaka Furue
Nov 12, 2003·The Journal of Pharmacology and Experimental Therapeutics·Takashi NozawaIkumi Tamai
Dec 21, 2004·Nuclear Medicine and Biology·Hideki MochizukiKiichi Ishiwata
Oct 21, 2005·British Journal of Clinical Pharmacology·Catharina M van RijEric J F Franssen
Feb 4, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Rikiya OhashiIkumi Tamai

❮ Previous
Next ❯

Citations

Jan 10, 2012·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Hancheng CaiHarry T Chugani
Aug 7, 2010·Drugs·Katherine A Lyseng-Williamson
Sep 12, 2013·Journal of Chromatographic Science·Yun Kyoung ChoiJi Hoon Jeong
Apr 9, 2013·Psychopharmacology·Silke ConenJohannes G Ramaekers
Apr 28, 2011·Expert Opinion on Drug Safety·Kazuhiko YanaiNobuyuki Okamura
Jul 16, 2009·Drug Metabolism Reviews·Martin K ChurchMargherita Strolin Benedetti
Nov 7, 2013·Expert Opinion on Pharmacotherapy·Leonard BieloryAndrea McMunn
Aug 5, 2016·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Sylvain AuvitySalvatore Cisternino
Apr 22, 2011·Journal of Clinical Psychopharmacology·Silke ConenJohannes G Ramaekers
May 15, 2008·British Journal of Clinical Pharmacology·J M Ritter
Feb 12, 2010·Allergy·M K ChurchUNKNOWN Global Allergy and Asthma European Network
Jun 6, 2009·Expert Opinion on Pharmacotherapy·Harold W Goforth
Nov 29, 2013·Journal of Labelled Compounds & Radiopharmaceuticals·Uta FunkeAlbert D Windhorst
Sep 13, 2018·Expert Opinion on Pharmacotherapy·Ismael Carrillo-MartinVes Dimov
Jul 25, 2019·Pharmacology Research & Perspectives·Tadaho NakamuraNobuyuki Okamura
Jun 12, 2021·The Journal of Allergy and Clinical Immunology. in Practice·Désirée Larenas-Linnemann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.